Skip to main content

News & Announcements

Senescent brain cells may contribute to Alzheimer’s disease

Blood marker shows potential for tracking frontotemporal dementia

Virtual workshop: Modeling basic mechanisms of brain aging and Alzheimer’s disease in vitro and in silico

Two molecular maps of blood vessels in the human brain reveal links to dementia

TREM2 protein seems to protect brain cells from toxic TDP-43 protein

Blocking hormone improves Alzheimer’s symptoms in mice

Aging disrupts the normal daily fluctuations of immune cell activity

Join the 2022 Alzheimer’s Disease-Related Dementias Summit

Imaging technique shows Alzheimer’s impact on brain connections

Inside the brain: The role of neuropathology in Alzheimer’s disease research

Workshop: Can Autism Spectrum Disorders Tell Us Anything About Alzheimer’s Disease?

APOE ε4 is not associated with increased risk for Alzheimer’s disease and dementia in American Indians

Scientists discover a new molecular pathway shared by two neurodegenerative disorders

Blood test can predict presence of beta-amyloid in the brain, new study finds

High blood pressure may lower or raise dementia risk among older adults depending on age

Cataract removal linked to a reduction in dementia risk

Study maps out genomic regions that may control levels of proteins linked to neurological disorders

Viagra associated with reduced risk of Alzheimer’s disease

Immune system may play harmful role in Lewy body dementia

Changes in a small area in the brainstem could help detect Alzheimer’s disease earlier

Ritalin reduced apathy in NIA-funded Alzheimer’s clinical trial

NIA-VA effort increases recruitment of veterans for Alzheimer’s research

Sex-specific differences in aging and Alzheimer’s disease may be tied to genetics

Mini-brain model of frontotemporal dementia demonstrates the stages of dysfunction that lead to cell death

A new strategy for Alzheimer’s disease treatment targets cell-wide protein malfunction